“…While the use of mannose as a carbon source has received limited attention, the role of mannose in glycoprotein biogenesis has been well studied ( Ezekowitz et al, 1990 ; Chiba et al, 1998 ; Hamilton et al, 2003 ; Zhu et al, 2009 ; Tiels et al, 2012 ). More recently, Y. lipolytica has been explored as a host for the production of therapeutic mannoproteins due to its efficient heterologous protein secretory capabilities and the growing set of genetic tools available, such as a suite of promoters and terminators ( Thevenieau et al, 2009 ; Blazeck et al, 2011 , 2013 ; Curran et al, 2015 ; Shabbir Hussain et al, 2016 , 2017 ), pooled promoters ( Dulermo et al, 2017 ), secretion markers ( Nicaud et al, 2002 ; Madzak et al, 2004 ), Golden Gate assembly ( Celińska et al, 2017 ), and CRISPR systems ( Gao S. et al, 2016 ; Schwartz et al, 2016 , 2017b ). Mannosylphosphorylated N -glycans are a precursor to produce mannose-6-phosphate containing glycoproteins.…”